Concepedia

Richard F. Dunne

RF

Statistics

Publications

40

Citations

4.8K

H-Index

25

Active since

1988

Affiliations

University of Rochester Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Harvard University

Richard F. Dunne is an author at University of Rochester Medical Center specializing in medicine, oncology, and pancreatic cancer.

Publications per year

1988–2025

40

Publications

40

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Julio García‐Aguilar, Sujata Patil, Marc J. Gollub et al. · Journal of Clinical Oncology · 2022 · 906 citations · Full text

Medicine, Oncology, Surgery +17

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study

Supriya G. Mohile, Mostafa Mohamed, Huiwen Xu et al. · The Lancet · 2021 · 551 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Floris S. Verheij, Dana M. Omer, Hannah Williams et al. · Journal of Clinical Oncology · 2023 · 321 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +1

Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition

David Fabrizio, Thomas J. George, Richard F. Dunne et al. · Journal of Gastrointestinal Oncology · 2018 · 271 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 40